"Ethiodized Oil" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Ethyl ester of iodinated fatty acid of poppyseed oil. It contains 37% organically bound iodine and has been used as a diagnostic aid (radiopaque medium) and as an antineoplastic agent when part of the iodine is 131-I. (From Merck Index, 11th ed)
- Ethiodized Oil
- Oil, Ethiodized
- Ethiodized Oil (Injection)
- Ethiodized Oils
- Oils, Ethiodized
- Lipiodol UltraFluid
- UltraFluid, Lipiodol
Below are MeSH descriptors whose meaning is more general than "Ethiodized Oil".
Below are MeSH descriptors whose meaning is more specific than "Ethiodized Oil".
This graph shows the total number of publications written about "Ethiodized Oil" by people in this website by year, and whether "Ethiodized Oil" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Ethiodized Oil" by people in Profiles.
Moriguchi M, Takakuwa T, Kageyama K, Okamura H, Nanno S, Nishimoto M, Nakashima Y, Koh H, Nakane T, Yamamoto A, Nakamae H, Hino M. [Diffuse large B-cell lymphoma with markedly improved chylothorax by lymphangiography]. Rinsho Ketsueki. 2021; 62(6):554-559.
Taupin D, Mukherjee V, Nathavitharana R, Green DA, Fridman D. Lipiodol embolism following transarterial chemoembolization: an atypical case. Crit Care Med. 2014 Jun; 42(6):e481-4.
Khan W, Sullivan KL, McCann JW, Gonsalves CF, Sato T, Eschelman DJ, Brown DB. Moxifloxacin prophylaxis for chemoembolization or embolization in patients with previous biliary interventions: a pilot study. AJR Am J Roentgenol. 2011 Aug; 197(2):W343-5.
Brown DB, Pilgram TK, Darcy MD, Fundakowski CE, Lisker-Melman M, Chapman WC, Crippin JS. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents. J Vasc Interv Radiol. 2005 Dec; 16(12):1661-6.